KIYATEC VHM™ technology involves a novel device and associated method used to culture multiple human cell types toward viable three-dimensional tissue constructs that better represent the natural physiology of the human body.  VHM™ diagnostics hold the potential to enhance information derived from pre-clinical drug studies by providing an experimental system that improves the correlation between lab-based results and clinical patient response.  KIYATEC VHM™ technology comprises a novel bioreactor system designed to produce a viable lab-based human tissue model capable of overcoming common deficiencies encountered with existing pre-clinical drug discovery methods.  The end goal of delivering a robust VHM™ bench-top drug diagnostic instrument seeks to ultimately reduce the time and cost associated with pre-clinical drug discovery while providing comparable and enhanced information critical to pharmaceutical clients for use in the regulatory approval process.  In essence, capturing drug "failures" earlier in the discovery process.